Skip to content
healthcare.dev

CABOMETYX

NDC 42388-023, cabozantinib, tablet, from Exelixis, Inc..

Product NDC
42388-023
Status
Listed
Labeler
Exelixis, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42388-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CABOZANTINIB S-MALATE60 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
42388-023-264238800232630 TABLET in 1 BOTTLE (42388-023-26)
42388-023-364238800233630 TABLET in 1 BOTTLE (42388-023-36)
42388-023-374238800233715 TABLET in 1 BOTTLE (42388-023-37)
42388-023-46423880023461 BOTTLE in 1 CARTON (42388-023-46) / 30 TABLET in 1 BOTTLE
42388-023-57423880023571 BOTTLE in 1 CARTON (42388-023-57) / 15 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3850cce2-6137-42e5-a792-d318c4a4b3b5

Use it

Look up 42388-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42388-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42388-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.